164 related articles for article (PubMed ID: 26184130)
21. Synthesis and optimization of an original V-shaped collection of 4-7-disubstituted pyrido[3,2-d]pyrimidines as CDK5 and DYRK1A inhibitors.
Dehbi O; Tikad A; Bourg S; Bonnet P; Lozach O; Meijer L; Aadil M; Akssira M; Guillaumet G; Routier S
Eur J Med Chem; 2014 Jun; 80():352-63. PubMed ID: 24793883
[TBL] [Abstract][Full Text] [Related]
22. Design, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3.
Oukoloff K; Coquelle N; Bartolini M; Naldi M; Le Guevel R; Bach S; Josselin B; Ruchaud S; Catto M; Pisani L; Denora N; Iacobazzi RM; Silman I; Sussman JL; Buron F; Colletier JP; Jean L; Routier S; Renard PY
Eur J Med Chem; 2019 Apr; 168():58-77. PubMed ID: 30798053
[TBL] [Abstract][Full Text] [Related]
23. Suzuki-type Pd(0) coupling reactions in the synthesis of 2-arylpurines as Cdk inhibitors.
Vandromme L; Piguel S; Lozach O; Meijer L; Legraverend M; Grierson DS
Bioorg Med Chem Lett; 2006 Jun; 16(12):3144-6. PubMed ID: 16616489
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of 5-(3-(pyrazin-2-yl)benzylidene)thiazolidine-2,4-dione derivatives as pan-pim kinases inhibitors.
Lee J; Park J; Hong VS
Chem Pharm Bull (Tokyo); 2014; 62(9):906-14. PubMed ID: 24954014
[TBL] [Abstract][Full Text] [Related]
25. Practical one-pot two-step protocol for the microwave-assisted synthesis of highly functionalized rhodanine derivatives.
Radi M; Botta L; Casaluce G; Bernardini M; Botta M
J Comb Chem; 2010; 12(1):200-5. PubMed ID: 20028090
[TBL] [Abstract][Full Text] [Related]
26. Discovery of novel glycogen synthase kinase-3α inhibitors: Structure-based virtual screening, preliminary SAR and biological evaluation for treatment of acute myeloid leukemia.
Wang Y; Dou X; Jiang L; Jin H; Zhang L; Zhang L; Liu Z
Eur J Med Chem; 2019 Jun; 171():221-234. PubMed ID: 30925338
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and biological evaluation of 5-benzylidene-2-iminothiazolidin-4-ones as selective GSK-3β inhibitors.
Arfeen M; Bhagat S; Patel R; Prasad S; Roy I; Chakraborti AK; Bharatam PV
Eur J Med Chem; 2016 Oct; 121():727-736. PubMed ID: 27423119
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological activities of aminopyrimidyl-indoles structurally related to meridianins.
Akue-Gedu R; Debiton E; Ferandin Y; Meijer L; Prudhomme M; Anizon F; Moreau P
Bioorg Med Chem; 2009 Jul; 17(13):4420-4. PubMed ID: 19477650
[TBL] [Abstract][Full Text] [Related]
29. Butyrolactone I derivatives from Aspergillus terreus carrying an unusual sulfate moiety.
Niu X; Dahse HM; Menzel KD; Lozach O; Walther G; Meijer L; Grabley S; Sattler I
J Nat Prod; 2008 Apr; 71(4):689-92. PubMed ID: 18271552
[TBL] [Abstract][Full Text] [Related]
30. A practical multi-step synthesis of ethyl N-functionalized [Formula: see text]-amino benzimidazole acrylate derivatives as promising cytotoxic agents.
Ambeu CN; Le Guével R; Corlu A; Mamyrbekova JA; Bazureau JP
Mol Divers; 2018 Aug; 22(3):685-708. PubMed ID: 29623536
[TBL] [Abstract][Full Text] [Related]
31. Identification of glycogen synthase kinase-3 inhibitors with a selective sting for glycogen synthase kinase-3α.
Lo Monte F; Kramer T; Gu J; Anumala UR; Marinelli L; La Pietra V; Novellino E; Franco B; Demedts D; Van Leuven F; Fuertes A; Dominguez JM; Plotkin B; Eldar-Finkelman H; Schmidt B
J Med Chem; 2012 May; 55(9):4407-24. PubMed ID: 22533818
[TBL] [Abstract][Full Text] [Related]
32. 3H-pyrazolo[4,3-f]quinoline haspin kinase inhibitors and anticancer properties.
Opoku-Temeng C; Dayal N; Aflaki Sooreshjani M; Sintim HO
Bioorg Chem; 2018 Aug; 78():418-426. PubMed ID: 29698892
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of novel 5-substituted indirubins as protein kinases inhibitors.
Beauchard A; Ferandin Y; Frère S; Lozach O; Blairvacq M; Meijer L; Thiéry V; Besson T
Bioorg Med Chem; 2006 Sep; 14(18):6434-43. PubMed ID: 16759872
[TBL] [Abstract][Full Text] [Related]
34. Novel tetrahydropyrido[1,2-a]isoindolone derivatives (valmerins): potent cyclin-dependent kinase/glycogen synthase kinase 3 inhibitors with antiproliferative activities and antitumor effects in human tumor xenografts.
Boulahjar R; Ouach A; Matteo C; Bourg S; Ravache M; le Guével R; Marionneau S; Oullier T; Lozach O; Meijer L; Guguen-Guillouzo C; Lazar S; Akssira M; Troin Y; Guillaumet G; Routier S
J Med Chem; 2012 Nov; 55(22):9589-606. PubMed ID: 23083119
[TBL] [Abstract][Full Text] [Related]
35. GSK-3 mediates the okadaic acid-induced modification of collapsin response mediator protein-2 in human SK-N-SH neuroblastoma cells.
Ni MH; Wu CC; Chan WH; Chien KY; Yu JS
J Cell Biochem; 2008 Apr; 103(6):1833-48. PubMed ID: 17902168
[TBL] [Abstract][Full Text] [Related]
36. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and anticancer activity of novel bisindolylhydroxymaleimide derivatives with potent GSK-3 kinase inhibition.
Winfield HJ; Cahill MM; O'Shea KD; Pierce LT; Robert T; Ruchaud S; Bach S; Marchand P; McCarthy FO
Bioorg Med Chem; 2018 Aug; 26(14):4209-4224. PubMed ID: 30026041
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and biological evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β).
Zhang P; Hu HR; Bian SH; Huang ZH; Chu Y; Ye DY
Eur J Med Chem; 2013 Mar; 61():95-103. PubMed ID: 23047001
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of novel GSK-3β inhibitors as multifunctional agents against Alzheimer's disease.
Shi XL; Wu JD; Liu P; Liu ZP
Eur J Med Chem; 2019 Apr; 167():211-225. PubMed ID: 30772605
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological evaluation of new rhodanine analogues bearing 2-chloroquinoline and benzo[h]quinoline scaffolds as anticancer agents.
Ramesh V; Ananda Rao B; Sharma P; Swarna B; Thummuri D; Srinivas K; Naidu VG; Jayathirtha Rao V
Eur J Med Chem; 2014 Aug; 83():569-80. PubMed ID: 24996143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
